Peri-Operative Chemotherapy for Bladder Cancer: A Survey of Providers to Determine Barriers and Enablers-Reference-Cited by-同舟云学术

Peri-Operative Chemotherapy for Bladder Cancer: A Survey of Providers to Determine Barriers and Enablers

Published:2018-01-20 Issue:1 Volume:4 Page:49-65
ISSN:2352-3727
Container-title:Bladder Cancer
language:
Short-container-title:BLC

Author:

Walker Melanie¹²,Doiron R. Christopher³,French Simon D.²⁴,Brennan Kelly¹,Feldman-Stewart Deb¹⁵,Siemens D. Robert⁵³,Mackillop William J.¹⁵²,Booth Christopher M.¹⁵²

Affiliation:

1. Division of Cancer Care and Epidemiology, Queen’s University Cancer Research Institute, Queen’s University, ON, Canada

2. Department of Public Health Sciences, Queen’s University, ON, Canada

3. Department of Urology, Queen’s University, ON, Canada

4. School of Rehabilitation Therapy, Queen’s University, ON, Canada

5. Department of Oncology, Queen’s University, ON, Canada

Publisher

IOS Press

Subject

Urology,Oncology

Reference25 articles.

1. Invasive bladder cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up;Bellmunt;Ann Oncol,2009

2. Neoadjuvant chemotherapy should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer of the bladder (MIBC): A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process;Seah;Can Urol Assoc J,2013

3. Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement;Milowsky;J Clin Oncol,2016

4. Adjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis of individual patient data;Advanced Bladder Cancer Meta-analysis Collaboration;Eur Urol,2005

5. Benefits of Adjuvant Chemotherapy for Bladder Cancer;Booth;JAMA Oncol,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer;World Journal of Urology;2023-05-31

2. The utilization status of neoadjuvant chemotherapy in muscle-invasive bladder cancer: a systematic review and meta-analysis;Minerva Urology and Nephrology;2021-05

3. The utilization status of neoadjuvant chemotherapy in muscle-invasive bladder cancer: a systematic review and meta-analysis;MINERVA UROL NEPHROL;2021

4. Comparative Effectiveness of Treatment Strategies for Squamous Cell Carcinoma of the Bladder;European Urology Oncology;2020-08

5. Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer;Clinical Genitourinary Cancer;2020-06